|
Search
Collections
Benchmarks
Upload document
Organization
Cemka-Eval
Rename entity
Add alias
Merge entity
Delete entity
Embed entity
1 abstract
Abstract
BASELINE CHARACTERISTICS OF RHEUMATOID ARTHRITIS PATIENTS STARTING CERTOLIZUMAB PEGOL THERAPY AND GLUCOCORTICOID PRESCRIPTION IN THE ECLAIR STUDY IN 2012–2013
Org:
UCB Pharma,
Cemka-Eval,
